These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11421924)

  • 1. Mizolastine in the treatment of seasonal allergic rhinoconjunctivitis: a European clinical experience with 5408 patients managed in daily practice (PANEOS SAR Study).
    Bachert C; Vovolis V; Margari P; Murrieta-Aguttes M; Santoni JP
    Allergy; 2001 Jul; 56(7):653-9. PubMed ID: 11421924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the efficacy, safety, and onset of action of mizolastine, cetirizine, and placebo in the management of seasonal allergic rhinoconjunctivitis. MIZOCET Study Group.
    Sabbah A; Daele J; Wade AG; Ben-Soussen P; Attali P
    Ann Allergy Asthma Immunol; 1999 Oct; 83(4):319-25. PubMed ID: 10541424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mizolastine therapy also has an effect on nasal blockade in perennial allergic rhinoconjunctivitis. RIPERAN Study Group.
    Bachert C; Brostoff J; Scadding GK; Tasman J; Stalla-Bourdillon A; Murrieta M
    Allergy; 1998 Oct; 53(10):969-75. PubMed ID: 9821477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of mizolastine in seasonal allergic rhinitis. The Rhinase Study Group.
    Leynadier F; Bousquet J; Murrieta M; Attali P
    Ann Allergy Asthma Immunol; 1996 Feb; 76(2):163-8. PubMed ID: 8595536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mizolastine is effective and well tolerated in long-term treatment of perennial allergic rhinoconjunctivitis. Riperex Study Group.
    Scadding GK; Tasman AJ; Murrieta-Aguttes M; Bachert C
    J Int Med Res; 1999; 27(6):273-85. PubMed ID: 10726236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid symptom relief in rhinitis.
    Bousquet J
    Clin Exp Allergy; 1999 Mar; 29 Suppl 1():25-9. PubMed ID: 10209702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine.
    Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical examination of mizolastine in the seasonal allergic rhinitis].
    Li H; Zhang H; Yin J; Wang R; Fang Q
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Aug; 18(8):479-81. PubMed ID: 15571316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid and sustained efficacy of mizolastine 10 mg once daily in seasonal allergic rhinitis.
    Stern M; Blondin-Ertzbischoff P; Murrieta-Aguttes M; Hardwicke C; Emmerson EB; Judd MS
    J Int Med Res; 1998 Dec; 26(6):292-303. PubMed ID: 10399111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of bilastine upon the ocular symptoms of allergic rhinoconjunctivitis.
    Bartra J; Mullol J; Montoro J; Jáuregui I; del Cuvillos A; Dávila I; Ferrer M; Sastre J; Valero A
    J Investig Allergol Clin Immunol; 2011; 21 Suppl 3():24-33. PubMed ID: 22185047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can an antihistamine delay appearance of hay fever symptoms when given prior to pollen season?
    Stern MA; Darnell R; Tudor D
    Allergy; 1997 Apr; 52(4):440-4. PubMed ID: 9188928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
    Ciprandi G; Cirillo I; Vizzaccaro A
    Eur Ann Allergy Clin Immunol; 2004 Apr; 36(4):146-50. PubMed ID: 15180356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihistamines in rhinoconjunctivitis.
    Howarth P
    Clin Allergy Immunol; 2002; 17():179-220. PubMed ID: 12113217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical advantages of dual activity in allergic rhinitis.
    Horak F
    Allergy; 2000; 55 Suppl 64():34-9. PubMed ID: 11291779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion.
    Berger WE; Schenkel EJ; Mansfield LE;
    Ann Allergy Asthma Immunol; 2002 Nov; 89(5):485-91. PubMed ID: 12452207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis.
    Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A
    Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open-label safety assessment of bilastine in elderly patients with allergic rhinoconjunctivitis and/or urticaria.
    Sologuren A; Viñas R; Cordón E; Riesgo SE; Del Mar Forés M; Senán MR; Fernández S; Labeaga L; Ruiz-Miján M
    Allergy Asthma Proc; 2018 Jul; 39(4):299-304. PubMed ID: 29559031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study.
    Dubertret L; Murrieta Aguttes M; Tonet J
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria.
    Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P
    Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year treatment of chronic urticaria with mizolastine: efficacy and safety. URTOL study group.
    Lorette G; Giannetti A; Pereira RS; Leynadier F; Murrieta-Aguttes M
    J Eur Acad Dermatol Venereol; 2000 Mar; 14(2):83-90. PubMed ID: 10972091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.